Cargando…
Does information from ClinicalTrials.gov increase transparency and reduce bias? Results from a five-report case series
BACKGROUND: We investigated whether information in ClinicalTrials.gov would impact the conclusions of five ongoing systematic reviews. METHOD: We considered five reviews that included 495 studies total. Each review team conducted a search of ClinicalTrials.gov up to the date of the review’s last lit...
Autores principales: | Adam, Gaelen P., Springs, Stacey, Trikalinos, Thomas, Williams, John W., Eaton, Jennifer L., Von Isenburg, Megan, Gierisch, Jennifer M., Wilson, Lisa M., Robinson, Karen A., Viswanathan, Meera, Middleton, Jennifer Cook, Forman-Hoffman, Valerie L., Berliner, Elise, Kaplan, Robert M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902969/ https://www.ncbi.nlm.nih.gov/pubmed/29661214 http://dx.doi.org/10.1186/s13643-018-0726-5 |
Ejemplares similares
-
Registration of phase 3 crossover trials on ClinicalTrials.gov
por: Zeng, Lijuan, et al.
Publicado: (2020) -
2557 Improving ClinicalTrials.gov compliance: A coordinated effort for success
por: Patton, Scott, et al.
Publicado: (2018) -
Transparency of clinical trials in pancreatic cancer: An analysis of availability of trial results from the ClinicalTrials.gov database
por: Huang, Ren-Qian, et al.
Publicado: (2023) -
Some data quality issues at ClinicalTrials.gov
por: Chaturvedi, Neha, et al.
Publicado: (2019) -
Obstacles to the reuse of study metadata in ClinicalTrials.gov
por: Miron, Laura, et al.
Publicado: (2020)